Mobile Cancer Screening Act

HR 4417, the Mobile Cancer Screening Act, provides federal grants to fund new mobile cancer screening units targeting underserved communities. It directly affects nonprofit hospitals, community health centers, academic health centers, and health systems in rural areas or regions served by the Indian Health Service. The bill authorizes up to $2 million per grant to purchase vehicles, imaging technology, and digital tools for these units, requiring recipients to match federal funds at a 1:3 ratio. Grantees must provide follow-up care within 90 minutes for abnormal results and report de-identified patient data on screening rates and outcomes to Congress by 2031. The law allocates $15 million annually from 2027 through 2031 to expand access to early cancer screenings, particularly for lung and breast cancer.